SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy.
Millan, A. J., Allain, V., Nayak, I., Libang, J. B., Quijada-Madrid, L. M., Arakawa-Hoyt, J. S., … & Lanier, L. L.
The Journal of Immunology, vkaf012.
PUBMED: 40073103
https://doi.org/10.1093/jimmun/vkaf012